European Journal of Cancer
Volume 39, Issue 17 , Pages 2556-2565, November 2003

In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity:

implications in cancer chemotherapy

  • B Das

      Affiliations

    • New Agent and Innovative Therapy Program, Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Canada
  • ,
  • H Yeger

      Affiliations

    • Department of Pediatric Laboratory Medicine and Pathobiology, The Hospital for Sick Children, Toronto, Canada
  • ,
  • H Baruchel

      Affiliations

    • New Agent and Innovative Therapy Program, Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Canada
  • ,
  • M.H Freedman

      Affiliations

    • New Agent and Innovative Therapy Program, Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Canada
  • ,
  • G Koren

      Affiliations

    • Division of Clinical Pharmacology, The Hospital for Sick Children, Toronto, Canada
  • ,
  • S Baruchel

      Affiliations

    • New Agent and Innovative Therapy Program, Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1-416-813-5977; fax: +1-416-813-5327

Received 13 March 2003; received in revised form 4 June 2003; accepted 23 July 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(03)00677-4

doi:10.1016/j.ejca.2003.07.002

European Journal of Cancer
Volume 39, Issue 17 , Pages 2556-2565, November 2003